Viewing Study NCT00426205

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2025-12-31 @ 4:25 AM
Study NCT ID: NCT00426205
Status: COMPLETED
Last Update Posted: 2022-02-11
First Post: 2007-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome RAEB-I or RAEB-II View
None Refractory Acute Myeloid Leukemia View
None Refractory CML Myeloid Blast Crisis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GM-CSF View
None GVAX View
None Cancer vaccine View
None blood stem cell transplantation View
None MDS View
None AML View
None CML View